addiction

First Opinion By Sean Fogler

As a physician and a patient, I’ve seen the damage caused by the stigma of addiction. It must end

First Opinion By Richard Bottner, Christopher Moriates, and Matthew Stefanko

Stigma is killing people with substance use disorders. Health care providers need to rid themselves of it

Health By Alice Proujansky

Pregnancy poses challenges for people in recovery from substance use disorder. Covid-19 is taxing their support system

Health Tech By Erin Brodwin

Nearly a year since opening its doors, here’s how Verily’s addiction medicine campus is taking shape

Politics By Amy Sokolow

Opioid overdoses have skyrocketed amid the coronavirus, but states are nevertheless slashing addiction treatment program budgets 

Pharmalot By Ed Silverman

A pill to fight alcoholism causes an uproar in France over a regulator’s view of a clinical trial

Health By Lev Facher

Covid-19 has streamlined addiction medicine. Will the changes stick?

Pharmalot By Ed Silverman

Despite evidence, many primary care doctors don’t want to prescribe medications for addiction

Health By Alison Insinger

Methadone clinic lines and packed waiting rooms leave clients vulnerable to the coronavirus

First Opinion By Miriam Komaromy and Michael Botticelli

A radical approach to preventing Covid-19 infection in the homeless

First Opinion By Ximena A. Levander and Sarah E. Wakeman

Covid-19 will worsen the opioid overdose crisis if we don’t prepare now

First Opinion By Haider J. Warraich

What an 1890s opioid epidemic can teach us about ending addiction today

Business By Andrew Joseph

Prosecutors identified ‘Pharma Co. X’ as central to alleged opioid kickback scheme. Was it Purdue?

First Opinion By Lila Flavin and J. Wesley Boyd

A government database is supposed to help people seeking treatment for opioid addiction. It often doesn’t

Health By Andrew Joseph and Shraddha Chakradhar

Faced with prescriber fears of OxyContin misuse, Purdue sales reps misleadingly played up drug’s safety, documents show

Health Tech By Casey Ross

Pear Therapeutics licenses voice biomarkers for dementia and psychiatric disorders

First Opinion By William Stauffer

Addiction treatment is broken. Here’s what it should look like

Health By Lev Facher

This mental health advocate wants to make addiction and behavioral health a 2020 election issue

First Opinion By Lauren Lollini

A hospital staffer diverted drugs, which gave me hepatitis C. That happens more often than you think

Health By Andrew Joseph

National Academies outlines opioid guidelines, aiming to make approach to prescribing more consistent

First Opinion By Diane Dorman

Orphan Drug Act’s ‘nonprofitability’ loophole needs to be closed

Politics By Lev Facher

FDA blasts Alkermes for underselling the risks of opioid addiction drug Vivitrol

First Opinion By Patrick J. Kennedy

Mental health and addiction care are poorly covered by insurance networks

Health By Andrew Joseph

Tufts will scour Sackler name from its medical campus, in rebuff of family that controls Purdue Pharma

Exclusive By Casey Ross

Purdue’s Richard Sackler proposed plan to play down OxyContin risks, and wanted drug maker feared ‘like a tiger,’ files show